Antibiotic use and outcome in patients with negative blood cultures, a new target population for antimicrobial stewardship interventions : A prospective multicentre cohort (NO-BACT)
Copyright © 2023 The British Infection Association. Published by Elsevier Ltd. All rights reserved..
OBJECTIVES: To evaluate the appropriateness of antimicrobial treatment and the risk factors for mortality in patients with negative blood cultures (BC), in order to evaluate whether this population would be a suitable target for antimicrobial stewardship (AMS) interventions.
METHODS: A multicentre prospective cohort study of patients with negative BC in three Spanish hospitals between October 2018 and July 2019 was performed. The main endpoints were the appropriateness of antimicrobial treatment (evaluated by two investigators according to local guidelines) and 30-day mortality. Cox-regression was performed to estimate the association between variables and 30-day mortality.
RESULTS: Of 1011 patients in whom BC was obtained, these were negative in 803 (79%) and were included; 30-day mortality was 9% (70 patients); antibiotic treatment was considered inappropriate in 299 (40%) of 747 patients evaluated at day 2, and in 266 (46%) of 573 at day 5-7. The variables independently associated with increased risk of 30-day mortality were higher age (HR 1.05; 95% CI 1.03-1.07), neoplasia (HR 2.73; 95% CI 1.64-4.56), antibiotic treatment in the 48 h prior to BC extraction (HR 2.06; 95% CI 1.23-3.43) and insufficient antibiotic coverage at day 2 after BC obtainment (HR 2.35; 95% CI 1.39-4.00). Urinary, catheter and biliary sources of infection were associated with lower risk (HR 0.40; 95% CI 0.20-0.81).
CONCLUSIONS: Antimicrobial treatment is frequently inappropriate among patients with negative BC; insufficient antibiotic coverage at day 2 was associated with mortality. These results suggest that patients with negative BC are a suitable population for AS interventions.
SUMMARY: Antimicrobial treatment in patients with negative blood culture was frequently inappropriate, and inappropriate coverage at day 2 was associated with increased risk of death. These data support the consideration of this population as a potential target for antimicrobial stewardship interventions.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:88 |
---|---|
Enthalten in: |
The Journal of infection - 88(2024), 2 vom: 08. Feb., Seite 95-102 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Girón-Ortega, José Antonio [VerfasserIn] |
---|
Links: |
---|
Themen: |
Anti-Bacterial Agents |
---|
Anmerkungen: |
Date Completed 07.02.2024 Date Revised 07.02.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.jinf.2023.11.013 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM365273031 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM365273031 | ||
003 | DE-627 | ||
005 | 20240207232133.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.jinf.2023.11.013 |2 doi | |
028 | 5 | 2 | |a pubmed24n1283.xml |
035 | |a (DE-627)NLM365273031 | ||
035 | |a (NLM)38036182 | ||
035 | |a (PII)S0163-4453(23)00585-6 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Girón-Ortega, José Antonio |e verfasserin |4 aut | |
245 | 1 | 0 | |a Antibiotic use and outcome in patients with negative blood cultures, a new target population for antimicrobial stewardship interventions |b A prospective multicentre cohort (NO-BACT) |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 07.02.2024 | ||
500 | |a Date Revised 07.02.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2023 The British Infection Association. Published by Elsevier Ltd. All rights reserved. | ||
520 | |a OBJECTIVES: To evaluate the appropriateness of antimicrobial treatment and the risk factors for mortality in patients with negative blood cultures (BC), in order to evaluate whether this population would be a suitable target for antimicrobial stewardship (AMS) interventions | ||
520 | |a METHODS: A multicentre prospective cohort study of patients with negative BC in three Spanish hospitals between October 2018 and July 2019 was performed. The main endpoints were the appropriateness of antimicrobial treatment (evaluated by two investigators according to local guidelines) and 30-day mortality. Cox-regression was performed to estimate the association between variables and 30-day mortality | ||
520 | |a RESULTS: Of 1011 patients in whom BC was obtained, these were negative in 803 (79%) and were included; 30-day mortality was 9% (70 patients); antibiotic treatment was considered inappropriate in 299 (40%) of 747 patients evaluated at day 2, and in 266 (46%) of 573 at day 5-7. The variables independently associated with increased risk of 30-day mortality were higher age (HR 1.05; 95% CI 1.03-1.07), neoplasia (HR 2.73; 95% CI 1.64-4.56), antibiotic treatment in the 48 h prior to BC extraction (HR 2.06; 95% CI 1.23-3.43) and insufficient antibiotic coverage at day 2 after BC obtainment (HR 2.35; 95% CI 1.39-4.00). Urinary, catheter and biliary sources of infection were associated with lower risk (HR 0.40; 95% CI 0.20-0.81) | ||
520 | |a CONCLUSIONS: Antimicrobial treatment is frequently inappropriate among patients with negative BC; insufficient antibiotic coverage at day 2 was associated with mortality. These results suggest that patients with negative BC are a suitable population for AS interventions | ||
520 | |a SUMMARY: Antimicrobial treatment in patients with negative blood culture was frequently inappropriate, and inappropriate coverage at day 2 was associated with increased risk of death. These data support the consideration of this population as a potential target for antimicrobial stewardship interventions | ||
650 | 4 | |a Multicenter Study | |
650 | 4 | |a Journal Article | |
650 | 4 | |a Antimicrobial stewardship | |
650 | 4 | |a Antimicrobial treatment | |
650 | 4 | |a Blood cultures | |
650 | 4 | |a Mortality | |
650 | 4 | |a Risk factors | |
650 | 7 | |a Anti-Bacterial Agents |2 NLM | |
700 | 1 | |a Fernández-Guerrero, Raquel |e verfasserin |4 aut | |
700 | 1 | |a de Oca Arjona, Montserrat Montes |e verfasserin |4 aut | |
700 | 1 | |a Galán-Sanchez, Fátima |e verfasserin |4 aut | |
700 | 1 | |a Sagastizábal, Galadriel Pellejero |e verfasserin |4 aut | |
700 | 1 | |a Romea, Elena Morte |e verfasserin |4 aut | |
700 | 1 | |a de Cueto, Marina |e verfasserin |4 aut | |
700 | 1 | |a Garcia, Margarita Beltrán |e verfasserin |4 aut | |
700 | 1 | |a Palacios-Baena, Zaira |e verfasserin |4 aut | |
700 | 1 | |a Jorge, Silvia Jiménez |e verfasserin |4 aut | |
700 | 1 | |a Rodríguez-Baño, Jesús |e verfasserin |4 aut | |
700 | 1 | |a Retamar-Gentil, Pilar |e verfasserin |4 aut | |
700 | 0 | |a NO-BACT Team |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t The Journal of infection |d 1982 |g 88(2024), 2 vom: 08. Feb., Seite 95-102 |w (DE-627)NLM012791822 |x 1532-2742 |7 nnns |
773 | 1 | 8 | |g volume:88 |g year:2024 |g number:2 |g day:08 |g month:02 |g pages:95-102 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jinf.2023.11.013 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 88 |j 2024 |e 2 |b 08 |c 02 |h 95-102 |